Ashland Inc. (ASH) shareholders
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3025% above fair value
$76.47+1.20 (+1.59%)
Close on Nov 13, 2026Market cap $3.50BP/E –Yield 2.14%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
52M of 46M shares
Institutional holders
354
66 new, 56 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 5,643,843 | 12.30% | 13G (passive) amendment | Jun 30, 2026 |
| Si Gp Iii LLC Joint filing with Standard Investments LLC (8.94%), Standard Latitude Master Fund Ltd. (8.94%) and 3 more | 4,095,001 | 8.94% | 13D (active) amendment | May 15, 2026 |
| Franklin Resources, Inc. Joint filing with Franklin Mutual Advisers, LLC (7.90%) | 3,616,479 | 7.90% | 13G (passive) | Jun 30, 2026 |
| Standard Investments LLC Joint filing with Si Gp Iii LLC (7.87%), Standard Latitude Master Fund Ltd. (7.87%) and 3 more | 3,605,001 | 7.87% | 13D (active) amendment | May 11, 2026 |
| AQR Capital Management Holdings, LLC Joint filing with AQR Capital Management, LLC (7.56%) | 3,454,646 | 7.56% | 13G (passive) | Jun 30, 2025 |
| Standard Latitude Fund LP Joint filing with Standard Investments LLC (6.80%), Si Gp Iii LLC (6.80%) and 3 more | 3,115,001 | 6.80% | 13D (active) amendment | May 5, 2026 |
| Cooperman Leon G | 2,915,000 | 6.40% | 13G (passive) | Jul 29, 2026 |
| David J. Millstone Joint filing with Standard Investments LLC (5.70%), Si Gp Iii LLC (5.70%) and 3 more | 2,625,000 | 5.70% | 13D (active) | Nov 21, 2025 |
| Franklin Templeton, Inc. Joint filing with Franklin Mutual Advisers, LLC (5.60%) | 2,547,004 | 5.60% | 13G (passive) amendment | Sep 30, 2026 |
| Dimensional Fund Advisors LP | 2,496,021 | 5.50% | 13G (passive) | Mar 31, 2026 |
| Vanguard Portfolio Management | 2,482,141 | 5.42% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ASH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,712,189 | 12.47% | $376.38M | +1,417,278 | 0.01% |
| Standard Investments LLC | 4,525,001 | 9.88% | $298.15M | +1,900,001 | 15.44% |
| Franklin Resources Inc | 3,616,479 | 7.90% | $238.29M | +1,874,130 | 0.05% |
| Dimensional Fund Advisors LP | 2,486,307 | 5.43% | $163.82M | −9,714 | 0.03% |
| Vanguard Portfolio Management LLC | 2,462,838 | 5.38% | $162.28M | +267,893 | 0.01% |
| Vanguard Capital Management LLC | 2,063,055 | 4.51% | $135.93M | +10,513 | 0.00% |
| Massachusetts Financial Services Co /Ma/ | 2,037,663 | 4.45% | $134.26M | −777,224 | 0.04% |
| Frontier Capital Management Co LLC | 1,999,908 | 4.37% | $131.77M | +87,219 | 1.23% |
| Ancora Advisors, LLC | 1,945,412 | 4.25% | $128.18M | +1,945,112 | 2.47% |
| Cooperman Leon G | 1,895,000 | 4.14% | $124.86M | +195,000 | 3.52% |
| State Street Corp | 1,891,594 | 4.13% | $124.64M | +351,766 | 0.00% |
| Aqr Capital Management LLC | 1,823,353 | 3.98% | $116.77M | −188,171 | 0.04% |
| Diamond Hill Capital Management Inc | 1,600,714 | 3.50% | $105.47M | −149,773 | 0.84% |
| 1832 Asset Management L.P. | 1,409,124 | 3.08% | $92.85M | −6,296 | 0.05% |
| Geode Capital Management, LLC | 1,249,931 | 2.73% | $82.37M | +400,996 | 0.00% |
| Thrivent Financial for Lutherans | 1,029,179 | 2.25% | $67.81M | −627 | 0.11% |
| American Century Companies Inc | 919,239 | 2.01% | $60.57M | −221,460 | 0.03% |
| Northern Trust Corp | 760,083 | 1.66% | $50.08M | +274,809 | 0.01% |
| Empyrean Capital Partners, LP | 542,000 | 1.18% | $35.71M | – | 1.18% |
| Charles Schwab Investment Management Inc | 540,444 | 1.18% | $35.61M | +114,940 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 354 | 52M | 100.0% | 66 / 105 | 124 / 56 | 12M | 9M |
| Q1 2026 | 349 | 49M | 100.0% | 59 / 122 | 107 / 36 | 9M | 4M |
| Q4 2025 | 332 | 48M | 100.0% | 55 / 91 | 139 / 69 | 11M | 7M |
| Q3 2025 | 355 | 45M | 97.3% | 55 / 99 | 149 / 42 | 6M | 6M |
| Q2 2025 | 345 | 44M | 96.1% | 53 / 139 | 107 / 72 | 7M | 5M |
| Q1 2025 | 367 | 43M | 93.7% | 69 / 132 | 107 / 58 | 7M | 9M |
| Q4 2024 | 359 | 45M | 97.3% | 56 / 120 | 128 / 60 | 5M | 4M |
| Q3 2024 | 368 | 44M | 96.8% | 48 / 105 | 142 / 57 | 8M | 5M |
| Q2 2024 | 379 | 46M | 99.7% | 51 / 132 | 118 / 42 | 3M | 4M |
| Q1 2024 | 372 | 47M | 100.0% | 72 / 110 | 113 / 32 | 3M | 3M |
| Q4 2023 | 335 | 48M | 100.0% | 52 / 102 | 120 / 36 | 4M | 4M |
| Q3 2023 | 323 | 47M | 100.0% | 42 / 106 | 115 / 54 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
309 funds held ASH in Q2 2026, 46% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ASH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Franklin Small Cap Value Fund | 1,841,188 | 4.02% | $133.69M | 3.12% | Jul 31, 2026 |
| iShares Core S&P Mid-Cap ETF | 1,565,498 | 3.42% | $103.15M | 0.08% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,454,480 | 3.18% | $95.84M | 0.00% | Jun 30, 2026 |
| MFS Mid Cap Value Fund | 1,283,827 | 2.80% | $84.59M | 0.49% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,199,295 | 2.62% | $79.02M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,051,330 | 2.30% | $69.27M | 0.04% | Jun 30, 2026 |
| Thrivent Small Cap Stock Fund | 665,905 | 1.45% | $48.35M | 1.66% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 665,193 | 1.45% | $43.83M | 0.06% | Jun 30, 2026 |
| Franklin Small Cap Value VIP Fund | 652,030 | 1.42% | $42.96M | 3.28% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 608,227 | 1.33% | $44.16M | 0.23% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 525,834 | 1.15% | $34.65M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 508,244 | 1.11% | $36.90M | 0.11% | Jul 31, 2026 |
| Diamond Hill Long Short Fund | 494,019 | 1.08% | $32.55M | 1.54% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Value Fund | 444,010 | 0.97% | $29.26M | 0.28% | Jun 30, 2026 |
| MFS New Discovery Value Fund | 437,958 | 0.96% | $25.36M | 1.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Guillermo Novo | Chair of the Board and CEO, Director | 172,143 | 0.38% | Feb 10, 2026 |
| Osama M. Musa | SVP and CTO | 37,577 | 0.08% | Sep 23, 2026 |
| Robin E. Lampkin | SVP, GC & Secretary | 7,690 | 0.02% | Aug 12, 2026 |
| Alessandra Faccin Assis | SVP and GM, Life Sciences | 9,099 | 0.02% | Jul 29, 2026 |
| James P. Minicucci | SVP and GM, Personal Care | 8,567 | 0.02% | May 11, 2026 |
| William Whitaker | SVP, CFO & PFO | 2,082 | 0.00% | Nov 21, 2025 |
| Eileen Drury | SVP and Chief HRO | 7,601 | 0.02% | Nov 21, 2025 |
| Dago Caceres | SVP & GM, Specialty Additives | 746 | 0.00% | Nov 21, 2025 |
| Samuel Richardson | VP, Controller and PAO | 1,072 | 0.00% | Nov 21, 2025 |
| Eric N. Boni | VP, Finance & Prinpl Acctg Off | 22,770 | 0.05% | Dec 9, 2024 |
| J. Kevin Willis | SVP and CFO | 270,566 | 0.59% | Nov 20, 2024 |
| Karl R. Bostaph | Senior VP Operations | 7,165 | 0.02% | Nov 20, 2024 |
| Steven D. Bishop | Director | – | – | Oct 1, 2026 |
| Sanat Chattopadhyay | Director | – | – | Oct 1, 2026 |
| Allen A. Spizzo | Director | – | – | Aug 5, 2026 |
| Peter T. Thomas | Director | 4,500 | 0.01% | Aug 5, 2026 |
| Bertrand Loy | Director | – | – | May 18, 2026 |
| Ashish K. Kulkarni | Director | 2,113 | 0.00% | Jan 22, 2026 |
| Suzan F. Harrison | Director | 1,931 | 0.00% | Jan 22, 2026 |
| Sue Main | Director | 1,883 | 0.00% | Jan 21, 2026 |
| Jerome A. Peribere | Director | 1,883 | 0.00% | Jan 21, 2026 |
| Scott Tozier | Director | – | – | Jan 21, 2026 |
| Sergio Pedreiro | Director | – | – | Jan 23, 2025 |
| Janice Teal | Director | 1,883 | 0.00% | Jan 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Osama M. Musa SVP and CTO | Sep 21, 2026 | Tax withholding | −3,647 | $69.06 | $251.86K | 37,577 |
| Osama M. Musa SVP and CTO | Sep 21, 2026 | Option exercise | +10,418 | $69.06 | $719.47K | 41,224 |
| Robin E. Lampkin SVP, GC & Secretary | Aug 11, 2026 | Option exercise | +1,806 | $74.58 | $134.69K | 6,825 |
| Robin E. Lampkin SVP, GC & Secretary | Aug 11, 2026 | Tax withholding | −526 | $74.58 | $39.23K | 6,299 |
| Osama M. Musa SVP and CTO | Jul 29, 2026 | Option exercise | +1,267 | $57.96 | $73.44K | 30,806 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 27, 2026 | Option exercise | +3,215 | $66.38 | $213.41K | 9,099 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 27, 2026 | Tax withholding | −884 | $66.38 | $58.68K | 8,215 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2026 | Option exercise | +4,310 | $55.01 | $237.09K | 8,567 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2026 | Tax withholding | −1,346 | $55.01 | $74.04K | 7,221 |
| Ashish K. Kulkarni Director | Jan 21, 2026 | Option exercise | +2,113 | – | – | 2,113 |
| Samuel Richardson VP, Controller and PAO | Nov 17, 2025 | Tax withholding | −32 | $49.60 | $1.59K | 1,072 |
| Samuel Richardson VP, Controller and PAO | Nov 17, 2025 | Option exercise | +107 | $49.60 | $5.31K | 1,104 |
| Eileen Drury SVP and Chief HRO | Nov 17, 2025 | Tax withholding | −280 | $49.60 | $13.89K | 7,601 |
| Eileen Drury SVP and Chief HRO | Nov 17, 2025 | Option exercise | +567 | $49.60 | $28.12K | 7,881 |
| Osama M. Musa SVP and CTO | Nov 17, 2025 | Option exercise | +976 | $49.60 | $48.41K | 29,875 |
| Osama M. Musa SVP and CTO | Nov 17, 2025 | Tax withholding | −335 | $49.60 | $16.62K | 29,540 |
| William Whitaker SVP, CFO & PFO | Nov 17, 2025 | Option exercise | +107 | $49.60 | $5.31K | 2,082 |
| William Whitaker SVP, CFO & PFO | Nov 17, 2025 | Tax withholding | −33 | $49.60 | $1.64K | 2,049 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 17, 2025 | Tax withholding | −2,563 | $49.60 | $127.12K | 140,849 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 17, 2025 | Option exercise | +6,122 | $49.60 | $303.65K | 143,412 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 17, 2025 | Option exercise | +239 | $49.60 | $11.85K | 5,095 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 17, 2025 | Tax withholding | −72 | $49.60 | $3.57K | 5,023 |
| Osama M. Musa SVP and CTO | Nov 14, 2025 | Tax withholding | −717 | $51.51 | $36.93K | 28,899 |
| Osama M. Musa SVP and CTO | Nov 14, 2025 | Option exercise | +2,091 | $51.51 | $107.71K | 29,616 |
| Samuel Richardson VP, Controller and PAO | Nov 14, 2025 | Option exercise | +228 | $51.51 | $11.74K | 1,066 |
| Samuel Richardson VP, Controller and PAO | Nov 14, 2025 | Tax withholding | −69 | $51.51 | $3.55K | 997 |
| James P. Minicucci SVP and GM, Personal Care | Nov 14, 2025 | Option exercise | +1,225 | $51.51 | $63.10K | 4,640 |
| James P. Minicucci SVP and GM, Personal Care | Nov 14, 2025 | Tax withholding | −383 | $51.51 | $19.73K | 4,257 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 14, 2025 | Option exercise | +1,276 | $51.51 | $65.73K | 5,237 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 14, 2025 | Tax withholding | −381 | $51.51 | $19.63K | 4,856 |
| Eileen Drury SVP and Chief HRO | Nov 14, 2025 | Option exercise | +1,297 | $51.51 | $66.81K | 7,917 |
| Eileen Drury SVP and Chief HRO | Nov 14, 2025 | Tax withholding | −603 | $51.51 | $31.06K | 7,314 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 14, 2025 | Tax withholding | −3,817 | $51.51 | $196.61K | 137,290 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 14, 2025 | Option exercise | +9,119 | $51.51 | $469.72K | 141,107 |
| William Whitaker SVP, CFO & PFO | Nov 14, 2025 | Tax withholding | −108 | $51.51 | $5.56K | 1,975 |
| William Whitaker SVP, CFO & PFO | Nov 14, 2025 | Option exercise | +356 | $51.51 | $18.34K | 2,083 |
| Osama M. Musa SVP and CTO | Nov 13, 2025 | Option exercise | +1,393 | $53.10 | $73.97K | 28,002 |
| Osama M. Musa SVP and CTO | Nov 13, 2025 | Tax withholding | −477 | $53.10 | $25.33K | 27,525 |
| Samuel Richardson VP, Controller and PAO | Nov 13, 2025 | Option exercise | +146 | $53.10 | $7.75K | 882 |
| Samuel Richardson VP, Controller and PAO | Nov 13, 2025 | Tax withholding | −44 | $53.10 | $2.34K | 838 |
| James P. Minicucci SVP and GM, Personal Care | Nov 13, 2025 | Tax withholding | −319 | $53.10 | $16.94K | 3,415 |
| James P. Minicucci SVP and GM, Personal Care | Nov 13, 2025 | Option exercise | +1,020 | $53.10 | $54.16K | 3,734 |
| Dago Caceres SVP & GM, Specialty Additives | Nov 13, 2025 | Option exercise | +746 | $53.10 | $39.61K | 746 |
| Dago Caceres SVP & GM, Specialty Additives | Nov 13, 2025 | Tax withholding | −215 | $53.10 | $11.42K | 531 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 13, 2025 | Option exercise | +866 | $53.10 | $45.98K | 4,220 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 13, 2025 | Tax withholding | −259 | $53.10 | $13.75K | 3,961 |
| Eileen Drury SVP and Chief HRO | Nov 13, 2025 | Option exercise | +863 | $53.10 | $45.83K | 7,020 |
| Eileen Drury SVP and Chief HRO | Nov 13, 2025 | Tax withholding | −400 | $53.10 | $21.24K | 6,620 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Nov 13, 2025 | Option exercise | +1,340 | $53.10 | $71.15K | 6,286 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Nov 13, 2025 | Tax withholding | −570 | $53.10 | $30.27K | 5,716 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 13, 2025 | Tax withholding | −3,779 | $53.10 | $200.66K | 131,988 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 13, 2025 | Option exercise | +9,029 | $53.10 | $479.44K | 135,767 |
| William Whitaker SVP, CFO & PFO | Nov 13, 2025 | Option exercise | +229 | $53.10 | $12.16K | 1,797 |
| William Whitaker SVP, CFO & PFO | Nov 13, 2025 | Tax withholding | −70 | $53.10 | $3.72K | 1,727 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 25, 2025 | Tax withholding | −1,327 | $51.26 | $68.02K | 4,946 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 25, 2025 | Option exercise | +3,123 | $51.26 | $160.08K | 6,273 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2025 | Option exercise | +1,395 | $49.99 | $69.74K | 3,149 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2025 | Tax withholding | −435 | $49.99 | $21.75K | 2,714 |
| Ashish K. Kulkarni Director | May 6, 2025 | Option exercise | +1,032 | – | – | 1,032 |
| Guillermo Novo Chair of the Board and CEO, Director | Jan 31, 2025 | Buy | +31,294 | $64.24 | $2.01M | 31,294 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
12.34%
5M shares short
Days to cover
12.1
At 0M shares a day
Change since last report
+0.1%
From 5M shares
Short volume, 20 days
51.6%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ashland's stock actually held short. Settlement fails (shares not delivered on time) peaked at 14,906 shares on Sep 30, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Eric N. Boni Officer | Dec 5, 2024 | 451 | $35.21K | Dec 5, 2024 | Stock Appreciation Rights |
| Robin E. Lampkin Officer | Nov 19, 2024 | 162 | $12.24K | Nov 19, 2024 | Restricted Stock Vesting |
| Robin E. Lampkin Officer | Nov 15, 2024 | 868 | $67.62K | Nov 15, 2024 | Restricted Stock Vesting |
| J. Kevin Willis Officer | Sep 4, 2024 | 5,487 | $482.20K | Sep 4, 2024 | SAR |
| Swaminathan Ashok Kalyana Former Officer | Jun 3, 2024 | 6,829 | $677.11K | Jun 3, 2024 | Open Market Purchase |
| Min Chong Former Officer | May 7, 2024 | 758 | $74.74K | May 7, 2024 | Stock Appreciation Rights |
| Robin E. Lampkin Officer | Feb 16, 2024 | 844 | $78.10K | Feb 16, 2024 | Restricted Stock Vesting |
| Eric N. Boni Officer | Dec 7, 2023 | 843 | $69.45K | Dec 7, 2023 | Stock Appreciation Rights |
| J. Kevin Willis Officer | Sep 5, 2023 | 7,866 | $680.72K | Sep 5, 2023 | SAR |
See a number that looks wrong?